Lepu Scientech Medical Technology (Shanghai) Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
299.00
310.00
191.00
-17.00
79.00
86.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
0.00
0.00
-55.00
16.00
-3.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
245.00
250.00
193.00
77.00
126.00
66.00
Cash Flow from Investing Activities
25.00
-136.00
111.00
-472.00
-102.00
-9.00
Cash Flow from Financing Activities
-234.00
-213.00
-2.00
671.00
810.00
-53.00
Net Cash Inflow / Outflow
32.00
-98.00
295.00
269.00
837.00
3.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-3.00
1.00
-6.00
-7.00
2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Lepu Scientech Medical Technology (Shanghai) Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
299.830993190888
240.898669198392
59.00
24.46%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0
-111.828458325322
111.00
100.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
245.388000159425
245.83216601181
0.00
-0.18%
Cash Flow from Investing Activities
25.5533936841208
-80.7948220720942
105.00
131.63%
Cash Flow from Financing Activities
-234.854079417181
-231.078310076499
-3.00
-1.63%
Net Cash Inflow / Outflow
32.5263295708634
-82.9237414488227
114.00
139.22%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-3.5609848555013
-16.8827753120391
13.00
78.91%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -2.17% vs 29.70% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
245.39
250.84
-2.17%






